Market Closed - Nasdaq 04:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
139.5 USD -0.32% Intraday chart for DexCom, Inc. +5.24% +12.40%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Dexcom Insider Sold Shares Worth $579,180, According to a Recent SEC Filing MT
Dexcom Insider Sold Shares Worth $10,802,803, According to a Recent SEC Filing MT
Dexcom Insider Sold Shares Worth $2,715,006, According to a Recent SEC Filing MT
Dexcom Insider Sold Shares Worth $1,567,363, According to a Recent SEC Filing MT
Dexcom Insider Sold Shares Worth $1,182,680, According to a Recent SEC Filing MT
DexCom Initiated at Outperform by RBC, Price Target Set at $165 on View for Revenue Upside Amid Rapidly Expanding Market MT
DexCom is still in the running Our Logo
Sector Update: Health Care Stocks Higher Late Afternoon MT
Sector Update: Health Care Stocks Advance Wednesday Afternoon MT
DexCom Shares Rise After Prescription-Free Glucose Biosensor Wins FDA Clearance MT
US FDA clears use of first over-the-counter continuous glucose monitor RE
DexCom Says Prescription-Free Glucose Biosensor Wins FDA Clearance MT
US FDA clears use of first over-the-counter continuous glucose monitor RE
DexCom, Inc. Announces the FDA Clears Stelo by Dexcom ? the First Glucose Biosensor CI
DexCom Says Use of Automated Insulin Delivery System Reduces Hypoglycemia in Diabetes Patients MT
Transcript : DexCom, Inc. Presents at 45th Annual Raymond James Institutional Investors Conference 2024, Mar-05-2024 08:40 AM
DexCom, Inc. Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes with New Data at ATTD CI
ANALYST RECOMMENDATIONS : Airbnb, Conagra Brands, Berkshire Hathaway, Meta Platforms, Unilever.... Our Logo
UBS Adjusts DexCom Price Target to $153 From $149, Maintains Buy Rating MT
This time it's for real Our Logo
Bernstein Adjusts DexCom Price Target to $150 From $135, Maintains Outperform Rating MT
Leerink Partners Adjusts DexCom Price Target to $142 From $144, Maintains Outperform Rating MT
TD Cowen Adjusts DexCom Price Target to $160 From $110, Maintains Outperform Rating MT
Canaccord Genuity Adjusts DexCom Price Target to $144 From $137, Maintains Buy Rating MT
ANALYST RECOMMENDATIONS : Lululemon, Nvidia, PayPal, Spotify, Uber... Our Logo
Chart DexCom, Inc.
More charts
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 73.6% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
139.5 USD
Average target price
147.2 USD
Spread / Average Target
+5.54%
Consensus
  1. Stock
  2. Equities
  3. Stock DexCom, Inc. - Nasdaq
  4. News DexCom, Inc.
  5. DexCom In Talks To Buy Insulet, Sources Say